<?xml version="1.0" encoding="UTF-8"?>
<document id="29945888">
	<sentence id="s1" text="Here, we applied domain-focused CRISPR screening to human cancer cell lines to identify the transcription factor (TF) POU2F3 (POU class 2 homeobox 3; also known as SKN-1a/OCT-11) as a powerful dependency in a subset of SCLC lines.">
		<entity id="s1.e1" charOffset="58-64"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<entity id="s1.e2" charOffset="118-124"
			type="GENE" text="POU2F3" ontology_id="25833"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="An analysis of human SCLC specimens revealed that POU2F3 is expressed exclusively in variant SCLC tumors that lack expression of neuroendocrine markers and instead express markers of a chemosensory lineage known as tuft cells.">
		<entity id="s2.e1" charOffset="50-56"
			type="GENE" text="POU2F3" ontology_id="25833"/>
		<entity id="s2.e2" charOffset="98-103"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
	<sentence id="s3" text="Moreover, we show that most SCLC tumors can be classified into one of three lineages based on the expression of POU2F3, ASCL1, or NEUROD1.">
		<entity id="s3.e1" charOffset="33-38"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s3.e2" charOffset="112-118"
			type="GENE" text="POU2F3" ontology_id="25833"/>
		<entity id="s3.e3" charOffset="120-125"
			type="GENE" text="ASCL1" ontology_id="429"/>
		<entity id="s3.e4" charOffset="130-137"
			type="GENE" text="NEUROD1" ontology_id="4760"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
		<pair id="s3.p2" e1="s3.e1"
		    e2="s3.e3" pgr="true"/>
		<pair id="s3.p3" e1="s3.e1"
		    e2="s3.e4" pgr="false"/>
	</sentence>
</document>
